FRESENIUS KABI USA FDA Approval ANDA 210762

ANDA 210762

FRESENIUS KABI USA

FDA Drug Application

Application #210762

Documents

Letter2019-06-17

Application Sponsors

ANDA 210762FRESENIUS KABI USA

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 0.05MG BASE/ML0FENTANYL CITRATE PRESERVATIVE FREEFENTANYL CITRATE

FDA Submissions

UNKNOWN; ORIG1AP2019-05-03STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

FRESENIUS KABI USA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210762
            [companyName] => FRESENIUS KABI USA
            [docInserts] => ["",""]
            [products] => [{"drugName":"FENTANYL CITRATE PRESERVATIVE FREE","activeIngredients":"FENTANYL CITRATE","strength":"EQ 0.05MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/03\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/210762Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"05\/07\/2020","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-05-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.